Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of SEPsis SIGNs in Emergency Department

NCT04261621 is registered in ClinicalTrials.gov with BioMérieux as lead sponsor.

NCT NCT04261621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of SEPsis SIGNs in Emergency Department
Lead sponsor
BioMérieux
Phase
Observational
Overall status
Completed
Start date
July 6, 2020
Completion date
May 2, 2022
Enrollment
815 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

infection, sepsis